KOYOMINE

This brand name is authorized in Nigeria.

Active ingredients

The drug KOYOMINE contains one active pharmaceutical ingredient (API):

1	Promethazine UNII S5PUP23U26 - PROMETHAZINE TEOCLATE
	Promethazine is a potent, long acting, antihistamine with additional anti-emetic central sedative and anti-cholinergic properties.
	Read more about Promethazine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-2798	Tablet	KOYOMINE TABLET TAB 25 mg 520Tablet	KOYOMINE TABLET PROMETHAZINE THEOCLATE 25MG PROMETHAZINE TEOCLATE 25MG,Maize starch Bp Lactose BP Microcrystalline cellulose Bp Gelatin Bp Talcum Bp Mag Stearate Bp B4-2798 Drugs Imported Products 520Tablet Prescription Only Medicine (POM) 15/02/2021 NKOYO CHEMISTS LTD ., QUEEN BARRACKS ROAD, APAPA LAGOS LAGOS 8034144316 nkoyocoy@yahoo.com MANCARE PHARMACEUTICALS PVT, LTD, , MANCARE PHARMACEUTICALS PVT, LTD, PLOT NO, 59,60,85,86, V.M.I.E, DOWALI VILLAGE, VASAI (W), DIST, THANE, MAHARASHTRA,, India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R06AD02	Promethazine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AD Phenothiazine derivatives
Discover more medicines within R06AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-2798